SPROUTY-2 regulation and tumorigenic action in colon cancer

Antonio Barbáchano(Consejo Superior de Investigaciones Científicas), Alberto Muñoz Terol, Gemma Ferrer‐Mayorga(Consejo Superior de Investigaciones Científicas), Paloma Ordóñez‐Morán(University of Nottingham), María Jesús Larriba(Instituto de Investigaciones Biomédicas Sols-Morreale), José M. Rojas(Universidad de Antofagasta), José Manuel González‐Sancho(Consejo Superior de Investigaciones Científicas), Héctor G. Pálmer(CIBBIM-Nanomedicine), Eva Hernando(Eastern Cooperative Oncology Group), Fábio Pereira(Universidade Federal de Alfenas), Miguel F. Segura(Universitat Autònoma de Barcelona)
DIGITAL.CSIC (Spanish National Research Council (CSIC))
January 1, 2013
Cited by 0

Related Papers

Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
|Gut|2016|188
KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells
|Human Molecular Genetics|2011|182
Vitamin D Receptor Deficiency Enhances Wnt/β-Catenin Signaling and Tumor Burden in Colon Cancer
|PLoS ONE|2011|150
<i>HMGA2</i> Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes
|Cancer Research|2011|144
Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A.
|PubMed|2003|140